Rhabdomyolysis and Metabolic Myopathy

Gene: CACNA1S

Green List (high evidence)

CACNA1S (calcium voltage-gated channel subunit alpha1 S)
EnsemblGeneIds (GRCh38): ENSG00000081248
EnsemblGeneIds (GRCh37): ENSG00000081248
OMIM: 114208, Gene2Phenotype
CACNA1S is in 14 panels

4 reviews

Bryony Thompson (Royal Melbourne Hospital)

Comment on list classification: Second most common cause of malignant hyperthermia susceptibility after RYR1, but it is still a rare cause.
Created: 14 Apr 2023, 8:45 a.m. | Last Modified: 14 Apr 2023, 8:45 a.m.
Panel Version: 0.119

Mark Cleghorn (Royal Melbourne Hospital)

Green List (high evidence)

Primary phenotype hypokalemic episodic paralysis. Additional progressive myopathy phenotype seen in some individuals with hypoPP. Some reports of CACNA1S variants in congenital myopathy

PMID 35509735: 1 case: history consistent with episodic paralysis, developed progressive myopathy in 3rd decade (vacuolar histology), 200 gene myopathy panel (NGS + MLPA) identified CACNA1S pathogenic variant (p.Arg1239His). Segregated variant to affected father (pedigree states vacuolar myopathy)

PMID 28012042: 3 cases (infants) of congenital myopathy with single CACNA1S pathogenic variants (de novo) identified on exome sequencing, assumed dominant disease. Same paper also 4 cases of congenital myopathy with biallelic CACNA1S pathogenic variants. Western blot assays for CACNA1S protein in dominant cases below level of detection, suggesting loss of function mechanism. ?these 7 cases too young to display hypoPP phenotype

PMID 34763287: 1 case: 60yo with myopathy, CACNA1S missense variant on panel testing
Created: 8 Dec 2022, 6:30 a.m. | Last Modified: 8 Dec 2022, 6:30 a.m.
Panel Version: 0.133

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Hypokalemic periodic paralysis (MIM#170400)

Publications

Mode of pathogenicity
Other

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

11 patients from 7 families reported with perinatal hypotonia and weakness. AR / AD inheritance observed, PMID 28012042
Created: 15 Jun 2020, 8:51 a.m. | Last Modified: 15 Jun 2020, 8:51 a.m.
Panel Version: 0.185

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Phenotypes
Myopathy, congenital, due to dihydropyridine receptor defect, MIM# 620246

Publications

Elena Savva (Victorian Clinical Genetics Services)

Green List (high evidence)

PMID: 32104981 - 1 Japanese family with consistent childhood onset hypokalemic periodic paralysis. The proband manifested symptoms at 6 years old and her children at 4- and 2 years of age. Motor and language development normal.

PMID: 19118277 - Arg mutations within the S4 segments are enriched in this gene, including recurring mutations p.Arg528Gly, p.Arg528His, p.Arg1239Gly and p.Arg1239His. One patient with a novel missense was specifically noted as having onset "in the second decade".

PMID: 31380823 - 1 patient with onset at 14 years old following vigorous exercise

PMID: 30325262 - 5 patients with adult onset myopathy (60-80 years old). Some have reported skeletal muscle defects.

PMID: 30319441 - describes both LOF and GOF mechanisms for this gene

Summary: a wide age of onset but multiple paediatric reports.
Sources: Expert list
Created: 15 Jun 2020, 3:47 a.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Hypokalemic periodic paralysis, type 1 170400

Publications

Mode of pathogenicity
Other

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
  • Expert Review Green
  • Expert list
  • Royal Melbourne Hospital
Phenotypes
  • {Malignant hyperthermia susceptibility 5}, 601887
OMIM
114208
Clinvar variants
Variants in CACNA1S
Penetrance
None
Publications
Mode of Pathogenicity
Other
Panels with this gene

History Filter Activity

14 Apr 2023, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: cacna1s has been classified as Green List (High Evidence).

14 Apr 2023, Gel status: 3

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: cacna1s has been classified as Green List (High Evidence).

14 Apr 2023, Gel status: 3

Set mode of pathogenicity

Bryony Thompson (Royal Melbourne Hospital)

Mode of pathogenicity for gene: CACNA1S was changed from to Other

14 Apr 2023, Gel status: 3

Set publications

Bryony Thompson (Royal Melbourne Hospital)

Publications for gene: CACNA1S were set to 20301325

14 Apr 2023, Gel status: 3

Set publications

Bryony Thompson (Royal Melbourne Hospital)

Publications for gene: CACNA1S were set to

14 Jan 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Bryony Thompson (Royal Melbourne Hospital)

gene: CACNA1S was added gene: CACNA1S was added to Rhabdomyolysis_RMH. Sources: Royal Melbourne Hospital,Expert Review Green Mode of inheritance for gene: CACNA1S was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Phenotypes for gene: CACNA1S were set to {Malignant hyperthermia susceptibility 5}, 601887